228 related articles for article (PubMed ID: 33471718)
1. Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19.
Li J; Wei Q; Li WX; McCowen KC; Xiong W; Liu J; Jiang W; Marin T; Thomas RL; He M; Gongol B; Hepokoski M; Yuan JX; Shyy JY; Xiong N; Malhotra A
Endocr Pract; 2020 Oct; 26(10):1166-1172. PubMed ID: 33471718
[TBL] [Abstract][Full Text] [Related]
2. Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus.
Li J; Wei Q; McCowen KC; Xiong W; Liu J; Jiang W; Thomas RL; Hepokoski M; He M; Shyy JYJ; Malhotra A; Xiong N; Li WX
Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00301. PubMed ID: 34585841
[TBL] [Abstract][Full Text] [Related]
3. Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis.
Dimnjaković J; Buble T; Ivanko P; Poljičanin T; Karanović Štambuk S; Brborović H; Brborović O
PLoS One; 2024; 19(3):e0301056. PubMed ID: 38536830
[TBL] [Abstract][Full Text] [Related]
4. Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA.
Ghany R; Palacio A; Dawkins E; Chen G; McCarter D; Forbes E; Chung B; Tamariz L
Diabetes Metab Syndr; 2021; 15(2):513-518. PubMed ID: 33662839
[TBL] [Abstract][Full Text] [Related]
5. Effects of different treatments for type 2 diabetes mellitus on mortality of coronavirus disease from 2019 to 2021 in China: a multi-institutional retrospective study.
Xu K; He W; Yu B; Zhong K; Zhou D; Wang DW
Mol Biomed; 2024 May; 5(1):18. PubMed ID: 38755442
[TBL] [Abstract][Full Text] [Related]
6. Metformin and COVID-19: From cellular mechanisms to reduced mortality.
Scheen AJ
Diabetes Metab; 2020 Nov; 46(6):423-426. PubMed ID: 32750451
[TBL] [Abstract][Full Text] [Related]
7. Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis.
Luo P; Qiu L; Liu Y; Liu XL; Zheng JL; Xue HY; Liu WH; Liu D; Li J
Am J Trop Med Hyg; 2020 Jul; 103(1):69-72. PubMed ID: 32446312
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.
Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG
Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317
[TBL] [Abstract][Full Text] [Related]
9. Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus.
Li W; Li J; Wei Q; McCowen K; Xiong W; Liu J; Jiang W; Thomas R; Hepokoski M; He M; Shyy J; Malhotra A; Xiong N
Res Sq; 2021 Mar; ():. PubMed ID: 33791691
[TBL] [Abstract][Full Text] [Related]
10. Risk of Metformin in Patients With Type 2 Diabetes With COVID-19: A Preliminary Retrospective Report.
Gao Y; Liu T; Zhong W; Liu R; Zhou H; Huang W; Zhang W
Clin Transl Sci; 2020 Nov; 13(6):1055-1059. PubMed ID: 32955785
[TBL] [Abstract][Full Text] [Related]
11. Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort.
Wong CKH; Lui DTW; Lui AYC; Low MCH; Kwok ACY; Lau KTK; Au ICH; Xiong X; Chung MSH; Lau EHY; Cowling BJ
Front Endocrinol (Lausanne); 2022; 13():810914. PubMed ID: 35321338
[TBL] [Abstract][Full Text] [Related]
12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
13. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study.
Jiang N; Chen Z; Liu L; Yin X; Yang H; Tan X; Wang J; Li H; Tian M; Lu Z; Xiong N; Gong Y
Diabetes Res Clin Pract; 2021 Mar; 173():108619. PubMed ID: 33310173
[TBL] [Abstract][Full Text] [Related]
14. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
Cheng X; Xin S; Chen Y; Li L; Chen W; Li W; Zhou B; Li C; Gong Y; Li F; Duan P; Zhou X
Life Sci; 2021 Jun; 275():119371. PubMed ID: 33745895
[TBL] [Abstract][Full Text] [Related]
15. Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
Do JY; Kim SW; Park JW; Cho KH; Kang SH
Diabetes Metab; 2021 Jul; 47(4):101208. PubMed ID: 33160030
[TBL] [Abstract][Full Text] [Related]
16. Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes.
Chen X; Chen Y; Wu C; Wei M; Xu J; Chao YC; Song J; Hou D; Zhang Y; Du C; Li X; Song Y
BMJ Open Diabetes Res Care; 2020 Nov; 8(2):. PubMed ID: 33214191
[TBL] [Abstract][Full Text] [Related]
17. Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature.
Singh AK; Singh R; Saboo B; Misra A
Diabetes Metab Syndr; 2021; 15(1):159-167. PubMed ID: 33352455
[TBL] [Abstract][Full Text] [Related]
18. Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes.
Crouse AB; Grimes T; Li P; Might M; Ovalle F; Shalev A
Front Endocrinol (Lausanne); 2020; 11():600439. PubMed ID: 33519709
[TBL] [Abstract][Full Text] [Related]
19. A comment on metformin and COVID-19 with regard to "Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy".
Al-Salameh A; Wiernsperger N; Cariou B; Lalau JD
Diabetes Obes Metab; 2022 Sep; 24(9):1888-1893. PubMed ID: 35545864
[No Abstract] [Full Text] [Related]
20. Investigating the impact of metformin on severity of COVID-19 in patients with Type 2 diabetes mellitus: Focusing on laboratory findings.
Taheri R; Shahrokhi SZ; Amjadi Z; Kazerouni F
Endocrinol Diabetes Metab; 2023 Sep; 6(5):e441. PubMed ID: 37431844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
